Bristol-Myers lung cancer drug in trouble, stock p
Post# of 72440
Quote:
The company did not say whether the data was disappointing or merely insufficient to seek accelerated approval.
http://finance.yahoo.com/news/bristol-myers-s...05197.html
Quote:
The company did not say whether the data was disappointing or merely insufficient to seek accelerated approval.